Effects of an intravenous endotoxin challenge on glucose and insulin dynamics in horses

American Journal of Veterinary Research

Volumn 69, Issue 1, 2008, Pages 82-88

  Tóth, Ferenc ^a   Frank, Nicholas ^a   Elliott, Sarah B ^a   Geor, Raymond J ^b   Boston, Raymond C ^c  

^a UNIVERSITY OF TENNESSEE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLUCOSE; INSULIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; COLIC; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HORSE; INSULIN METABOLISM; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS ADMINISTRATION; LEUKOPENIA; MARE; NONHUMAN; PROVOCATION TEST;

ANIMALS; BLOOD GLUCOSE; CROSS-OVER STUDIES; FEMALE; HORSES; INSULIN; LIPOPOLYSACCHARIDES;

ANIMALIA; EQUIDAE; ESCHERICHIA COLI;

EID: 38749086479     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.1.82     Document Type: Article

References (52)

1. Morris DD. Endotoxemia in horses. A review of cellular and humoral mediators involved in its pathogenesis. J Vet Intern Med 1991;5:167-181.
2. Werners AH, Bull S, Fink-Gremmels J. Endotoxaemia: a review with implications for the horse. Equine Vet J 2005;37:371-383.
3. Larsen J. Acute colitis in adult horses. A review with emphasis on aetiology and pathogenesis. Vet Q 1997;19:72-80.
4. Morris DD, Moore JN. Antibody titres to core lipopolysaccharides in horses with gastrointestinal disorders which cause colic. Equine Vet J Suppl 1989;7:29-32.
5. French NP, Smith J, Edwards GB, et al. Equine surgical colic: risk factors for postoperative complications. Equine Vet J 2002;34:444-449.
6. Kahn CR. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 1978;27:1893-1902.
7. Agwunobi AO, Reid C, Maycock P, et al. Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 2000;85:3770-3778.
8. Virkamaki A, Yki-Jarvinen H. Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 1994;134:2072-2078.
9. Fessler JF, Bottoms GD, Roesel OF, et al. Endotoxin-induced change in hemograms, plasma enzymes, and blood chemical values in anesthetized ponies: effects of flunixin meglumine. Am J Vet Res 1982;43:140-144.
10. Ewert KM, Fessler JF, Templeton CB, et al. Endotoxin-induced hematologic and blood chemical changes in ponies: effects of flunixin meglumine, dexamethasone, and prednisolone. Am J Vet Res 1985;46:24-30.
11. Treiber RH, Kronfeld DS, Hess TM, et al. Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc 2006;228:1538-1545.
12. Pass MA, Pollitt S, Pollitt CC. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis? Equine Vet J Suppl 1998;26:133-138.
13. Moore JN, Garner HE, Shapland JE, et al. Prevention of endotoxin-induced arterial hypoxaemia and lactic acidosis with flunixin meglumine in the conscious pony. Equine Vet J 1981;13:95-98.
14. Doherty TJ, Andrews FM, Blackford JT, et al. Effects of lipopolysaccharide and phenylbutazone on gastric contents in the horse. Equine Vet J 2003;35:472-475.
15. Kiku Y, Kusano K, Miyake H, et al. Flow cytometric analysis of peripheral blood mononuclear cells induced by experimental endotoxemia in horse. J Vet Med Sci 2003;65:857-863.
16. Barton MH, Parviainen A, Norton N. Polymyxin B protects horses against induced endotoxaemia in vivo. Equine Vet J 2004;36:397-401.
17. MacKay RJ, Clark CK, Logdberg L, et al. Effect of a conjugate of polymyxin B-dextran 70 in horses with experimentally induced endotoxemia. Am J Vet Res 1999;60:68-75.
18. Parsons CS, Orsini JA, Krafty R, et al. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997-2004). J Am Vet Med Assoc 2007;230:885-889.
19. Sprouse RF, Garner HE, Green EM. Plasma endotoxin levels in horses subjected to carbohydrate induced laminitis. Equine Vet J 1987;19:25-28.
20. van Eps AW, Pollitt CC. Equine laminitis induced with oligofructose. Equine Vet J 2006;38:203-208.
21. Bailey SR, Marr CM, Elliott J. Current research and theories on the pathogenesis of acute laminitis in the horse. Vet J 2004;167:129-142.
22. van Eps AW, Pollitt CC. Equine laminitis: cryotherapy reduces the severity of the acute lesion. Equine Vet J 2004;36:255-260.
23. Harris P, Bailey SR, Elliott J, et al. Countermeasures for pasture-associated laminitis in ponies and horses. J Nutr 2006;136:2114S-2121S.
24. Al Jassim RA, Scott PT, Trebbin AL., et al. The genetic diversity of lactic acid producing bacteria in the equine gastrointestinal tract. FEMS Microbial Lett 2005;248:75-81.
25. Elliott J, Bailey SR. Gastrointestinal derived factors are potential triggers for the development of acute equine laminitis. J Nutr 2006;136:2103S-2107S.
26. Kronfeld DS, Treiber KH, Geor RJ. Comparison of nonspecific indications and quantitative methods for the assessment of insulin resistance in horses and ponies. J Am Vet Med Assoc 2005;226:712-719.
27. Hoffman RM, Boston RC, Stefanovski D, et al. Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. J Anim Sci 2003;81:2333-2342.
28. Treiber KH, Kronfeld DS, Geor RJ. Insulin resistance in equids: possible role in laminitis. J Nutr 2006;136:2094S-2098S.
29. Bergman RN. Minimal model: perspective from 2005. Horm Res 2005;64(suppl 3):8-15.
30. Henneke DR, Potter GD, Kreider JL, et al. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 1983;15:371-372.
31. Freestone JF, Wolfsheimer KJ, Kamerling SG, et al. Exercise induced hormonal and metabolic changes in Thoroughbred horses: effects of conditioning and acepromazine. Equine Vet J 1991;23:219-223.
32. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456-1467.
33. Boston RC, Stefanovski D, Moate PJ, et al. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 2003;5:1003-1015.
34. Duncan JR, Prasse KW, Mahaffey EA. Veterinary laboratory medicine. 3rd ed. Ames, Iowa: Iowa State University Press, 1994;229-238.
35. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-191.
36. Hardie EM, Kruse-Elliott K. Endotoxic shock. Part II: a review of treatment. J Vet Intern Med 1990;4:306-314.
37. Werners AH, Bull S, Vendrig JC, et al. Genotyping of Toll-like receptor 4, myeloid differentiation factor 2 and CD-14 in the horse: an investigation into the influence of genetic polymorphisms on the LPS induced TNF-alpha response in equine whole blood. Vet Immunol Immunopathol 2006;111:165-173.
38. Pratt SE, Geor RJ, McCutcheon LJ. Repeatability of 2 methods for assessment of insulin sensitivity and glucose dynamics in horses. J Vet Intern Med 2005;19:883-888.
39. Treiber KH, Kronfeld DS, Hess TM, et al. Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am J Vet Res 2005;66:2114-2121.
40. Treiber KH, Hess TM, Kronfeld DS, et al. Insulin resistance and compensation in laminitis-predisposed ponies characterized by the minimal model. Pferdeheilkunde 2005;21:91-92.
41. Jeffcott LB, Field JR, McLean JG, et al. Glucose tolerance and insulin sensitivity in ponies and Standardbred horses. Equine Vet J 1986;18:97-101.
42. Rijnen KE, van der Kolk JH. Determination of reference range values indicative of glucose metabolism and insulin resistance by use of glucose clamp techniques in horses and ponies. Am J Vet Res 2003;64:1260-1264.
43. McCowen KC, Ling PR, Ciccarone A, et al. Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med 2001;29:839-846.
44. Rui L, Aguirre V, Kim JK, et al. Insulin/IGF-l and TNF-alpha stimulate phosphorylation of IRS-l at inhibitory Ser307 via distinct pathways. J Clin Invest 2001;107:181-189.
45. Kawai Y, Ishizuka T, Kajita K, et al. Inhibition of PKCbeta improves glucocorticoid-induced insulin resistance in rat adipocytes. IUBMB Life 2002;54:365-370.
46. Krabbe KS, Bruunsgaard H, Qvist J, et al. Hypotension during endotoxemia in aged humans. Eur J Anaesthesiol 2001;18:572-575.
47. Hunt DG, Ivy JL. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol 2002;93:1638-1643.
48. Vicini P, Avogaro A, Spilker ME, et al. Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach. Am J Physiol Endocrinol Metab 2002;283:E78-E84.
49. Mobasheri A, Critchlow K, Clegg PD, et al. Chronic equine laminitis is characterised by loss of GLUT1, GLUT4 and ENaC positive laminar keratinocytes. Equine Vet J 2004;36:248-254.
50. Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006;113:1888-1904.
51. Katwa LC, Johnson PJ, Ganjam VK, et al. Expression of endothelin in equine laminitis. Equine Vet J 1999;31:243-247.
52. Eades SC, Stokes AM, Johnson PJ, et al. Serial alterations in digital hemodynamics and endothelin-1 immunoreactivity, platelet-neutrophil aggregation, and concentrations of nitric oxide, insulin, and glucose in blood obtained from horses following carbohydrate overload. Am J Vet Res 2007;68: 87-94.